Embolex and Heart attack - a phase IV clinical study of FDA data

Summary:

Heart attack is reported as a side effect among people who take Embolex (dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Acetylsalicylic Acid, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Heart attack when taking Embolex. It is created by eHealthMe based on reports of 1,159 people who have side effects when taking Embolex from the FDA, and is updated regularly.

What is Embolex?

Embolex has active ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride. eHealthMe is studying from 1,161 Embolex users. Check the latest studies of Embolex.

What is Heart attack?

Heart attack is found to be associated with 2,475 drugs and 3,298 conditions by eHealthMe. Check the latest studies of Heart attack.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 28, 2026

1,159 people reported to have side effects when taking Embolex.
Among them, 34 people (2.93%) have Heart attack.

Among these 34 people:

How long have people been on Embolex when they have Heart attack? *

What is the gender of people who have Heart attack when taking Embolex? *

female: 78.12 %
male: 21.88 %

What is the age of people who have Heart attack when taking Embolex? *

What are other drugs people take besides Embolex? *

What are other side effects people have besides Heart attack? *

Activated Partial Thromboplastin Time Prolonged: 20 people, 58.82%
Coagulation Factor V Level Decreased: 20 people, 58.82%
Thrombosis (formation of a blood clot inside a blood vessel): 20 people, 58.82%
Laboratory Test Abnormal: 18 people, 52.94%
Nosebleed (bleeding from nose): 15 people, 44.12%
Urinary Bladder Haemorrhage (urinary bladder bleeding): 15 people, 44.12%
Eye Haemorrhage (bleeding in the eye): 15 people, 44.12%
Gingival Bleeding (bleeding gums): 15 people, 44.12%
Haematoma (collection of blood outside the blood vessels): 15 people, 44.12%
Haemorrhage (bleeding): 15 people, 44.12%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 16 people, 47.06%
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 11 people, 32.35%
Pain: 4 people, 11.76%
Thrombophlebitis Superficial (swelling (inflammation) of a superficial vein caused by a blood clot): 4 people, 11.76%
Thyroid Diseases: 3 people, 8.82%
Fungal Infection: 3 people, 8.82%
Anaemia (lack of blood): 3 people, 8.82%
Arrhythmias (irregular heartbeat): 3 people, 8.82%
Blood Calcium Increased: 3 people, 8.82%
Cerebral Haemorrhage (bleeding within the brain): 3 people, 8.82%

* Approximation only. Some reports may have incomplete information.

Do you take Embolex and have Heart attack?

- Check whether Heart attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Embolex:

Embolex (1,161 reports)

Heart attack treatments and more:

Heart attack (266,145 reports)

How severe was Heart attack and when was it recovered:

Heart attack in Embolex

Expand to all the drugs that have ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride:

Heart attack and drugs with ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride (26 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Embolex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart attack:

Heart attack (2,475 drugs)

Browse all the conditions that are associated with Heart attack:

Heart attack (3,298 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride (the active ingredients of Embolex) and Embolex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.